Clinical trial
Safety Study of Hemospan® in Prostatectomy Patients
NCT00425334 · Sangart, Industry · Completed
Key facts
| NCT number | NCT00425334 |
|---|---|
| Title | Safety Study of Hemospan® in Prostatectomy Patients |
| Official title | A Clinical Safety (Phase II) Increasing Dose Study of MP4 (Hemospan®) in Total Prostatectomy Surgical Patients |
| Lead sponsor | Sangart, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Blood Loss, Surgical, Prostate Cancer, Surgery |
| Intervention type | Drug |
| Interventions | Hemospan (MP4OX), Ringer's lactate |
| Enrollment | 20 |
| Start date | Jul 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jan 22, 2007 |
| Last update posted | Aug 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: